Log in to MyACC
Renal Denervation: The Hypertension Care Team Approach
Get a jump start on ACC.26 by attending Renal Denervation: The Hypertension Care Team Approach on Friday, March 27, 2026, from noon to 3:45 p.m.
Course Chairs Eugene Yang, MD, MS, FACC and Tiffany C. Randolph, MD, MHA, FACC along with other leading experts, will provide an update on contemporary approaches and the latest best practice guidelines on hypertension management. Topics include the role of renal denervation as a treatment for uncontrolled or resistant hypertension, updated hypertension guidelines and current recommendations for renal denervation, strategies for determining which patients with uncontrolled or resistant hypertension are best suited for renal denervation and how to incorporate the procedure into patient management care plans.
Live demonstration stations will give attendees hands-on experience with renal denervation technology.
This course will educate the cardiac care team on the safety and efficacy of renal denervation, along with understanding its value as a potential option for their patients.
Education grant support for this activity provided by: Medtronic
Goal
The overall goal of this education is for participants to be able to recognize the role of renal denervation as a treatment for uncontrolled or resistant hypertension, discuss updated hypertension guidelines and current recommendations for renal denervation, and determine which patients with uncontrolled or resistant hypertension are best suited for renal denervation to incorporate the procedure into patient management care plans.
- Discuss the latest guidelines for managing hypertension in relation to current recommendations for renal denervation as a treatment for resistant or uncontrolled hypertension.
- Assess advanced hypertension management care plans and team-based care approaches for when to consider renal denervation treatment.
- Analyze how renal denervation may impact management for patients with hypertension in various practice environments, including roles of the healthcare team, reimbursement, and procedural considerations.
Target Audience
- General cardiologists
- Hypertension specialists
- Advanced practice providers including nurse practitioners, physician associates and pharmacists
Coming soon!
Coming soon!
Registration is free. However, seats are limited so make sure to register for in-person participation today. The program starts with a complimentary lunch at noon.
If you are experiencing issues with registration, call Member Care at 800-253-4636 or 202-375-6000.
This course will be held at the Hilton New Orleans Riverside, Salon C and D.
The address is:
2 Poydras St.
New Orleans, LA 70130
The hotel is a 7-minute walk from the Ernest N. Morial Convention Center in New Orleans.
Coming soon!
Disclaimer Statement:
This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a clinician relative to diagnostic and treatment options for a specific patient's medical condition.
The American College of Cardiology Foundation (ACCF) does not warrant the completeness, accuracy or usefulness of any opinions, advice, services or other information provided through this activity. In no event will ACCF be liable for any decision made, or action taken, in reliance upon the information provided through this activity.
Accredited status does not imply endorsement by ACC of any commercial products displayed in conjunction with this activity.
ACCF reserves the right to modify faculty and program without notice.
Disclosure/Conflict of Interest Statement:
As a provider jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), the American College of Cardiology Foundation (ACCF) must ensure balance, independence, objectivity, and scientific rigor in all of their directly provided or jointly provided/co-provided educational activities. Planners, presenters, and other contributors, in a position to control the content are required to disclose to the audience all relevant financial relationships he/she and/or his/her spouse or domestic partner may have, occurring within the past 24 months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the contributor should disclose that the product is not labeled for the use under discussion or that the product is still investigational.
ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care and not a specific proprietary business or commercial interest. The intent of this disclosure is not to prevent participation in educational activities by persons with a financial or other relationship, but rather to provide learners with information on which they can make their own determination whether financial interests or relationships may influence the education activity.
ACCF assesses conflicts of interest (COI) with its faculty, planners, managers, staff and other individuals who are in a position to control the content of certified activities. All relevant potential conflicts of interest that are identified are thoroughly vetted by course directors, ACCF education staff, and members of the Accreditation Compliance Workgroup (ACWG) through a process that includes appropriate peer review for fair balance, scientific objectivity and validity, and patient care and safety recommendations.
ACCF has taken the necessary steps to ensure that all relevant financial relationships have been mitigated.
Please note ACCF staff and the ACWG members involved with this activity have nothing to disclose, unless otherwise noted.
